Henry J. Fuchs - 15 Mar 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: President, Worldwide R&D
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 15 Mar 2023
Net transactions value: -$3,783,824
Form type: 4
Filing time: 17 Mar 2023, 21:37:27 UTC
Previous filing: 02 Mar 2023
Next filing: 11 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Award	$0	+16,840	+7.9%	$0.000000	228,986	15 Mar 2023	Direct	F1
transaction	BMRN	Common Stock	Tax liability	$421,064	-4,799	-2.1%	$87.74	224,187	15 Mar 2023	Direct
transaction	BMRN	Common Stock	Tax liability	$3,362,760	-36,000	-16%	$93.41	188,187	16 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to buy Common Stock)	Award	$0	+38,450		$0.000000	38,450	15 Mar 2023	Common Stock	38,450	$87.74	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on March 15, 2023. Price not applicable.
F2	Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter.